Dave Dullum: No, I was just going to say, the weighted average yield, at least the way we are counting through the quarter and went up right about 1.3%. That’s obviously somewhat reflected as a result of that. But again, as I would say, I don’t know that we are going to start seeing much more necessarily increase in that just because of somewhat stabilization, I think in LIBOR. Sorry, I didn’t mean
Bryce Rowe: Got it. Maybe I didn’t €“ you are correct, Dave. Maybe I didn’t ask it the right way. But just kind of trying to understand whether the move that we have seen in rates, is it fully reflected in that 13.4% weighted average yield, or will you get some kind of carry-through here in the March quarter?
Rachael Easton: Yes. It is fully reflected in that 13.4%.
Bryce Rowe: Okay. That’s helpful. Let’s see, from a €“ and maybe to follow-up on some of Mickey’s questions around portfolio valuation. Dave, you mentioned, an overall net decline in portfolio valuation outside of Old World Christmas. But there were some notable increases from an appreciation perspective. So, can you talk about kind of what’s going on within several of those companies, is it higher EBITDA, higher multiples, just kind of curious how you are getting to some of those higher valuations?
Dave Dullum: Yes. So, I think if you look at €“ if I was to go through each one of these, I won’t honestly do that. But just to give you a general sense, companies such as, I don’t recall them all out necessarily, but like a Brunswick Bowling, Mason West, Dema, which is one of our more recent investments, Nth Degree, which we still now have a interesting investment in, Schilling, which is consumer, somewhat related, PSI Molded Plastics. All of those had increases fundamentally as a result of EBITDA appreciation, while there was a slight decline on multiples, which of course, we don’t create those that’s given to us. So, net-net, in those companies, as an example, we saw an ability as a result of the EBITDA increases to offset any sort of multiple decline, so to speak.
And then when you look at some of the others, Horizon, we mentioned that had a bit of a slight EBITDA decline and a multiple decline as well. Some of the others, Educators Resource, which is a very good company had a similar dynamic, B&T acquisition, similar dynamic. So, overall, I would say, the obvious question is, we have 25 companies in our portfolio, excuse me, which is down from 26 companies, because of the €“ we have exited one company, as I mentioned that we have had in the portfolio for some time. So, overall, I think the balance in the portfolio is very solid with the nature of the companies we have in the various industries that we are in. And as I look forward, obviously, hopefully, we will start seeing €“ I suspect we will see generally EBITDA for arguments sake just kind of continuing on a trailing 12 basis, which is obviously how we do our valuations.
We will probably stay relatively stable. I would expect we might see a few increases, but nothing on a negative side necessarily, and then multiples, who knows what that’s going to look like as we go through the end of this quarter. I would anticipate multiples would be probably, again, relatively stable, maybe slightly down.
Bryce Rowe: Okay. That’s helpful. Last one for me, around the dividend and the supplemental, it sounds like you have an intention of continuing the supplemental dividends as appropriate. Just curious kind of maybe where the estimated UTI balance is at this point? And how do you feel about that $0.48 annualized levels from a supplemental perspective, I guess how much visibility do you have into that?
